Infant vaccines

infant vaccines

Infant vaccines are not fit for purpose: We have discovered that the amount of aluminium an infant receives in a vaccine is akin to a lottery. While the amount expected to be injected, is indicated by manufacturers on the patient information leaflet supplied with the vaccine, this value bears little resemblance to the actual amount. […]

Read More… from Infant vaccines

COVID conspiracy theorists

conspiracy theorists

COVID-19 conspiracy theorists are more concerned about their own health and less concerned about the health of others, according to a study led by University of Queensland researchers. Professor Jolanda Jetten from the UQ School of Psychology said the research found conspiracy theorists were also more likely to respond to COVID-19 with self-focused strategies rather than strategies that assist society […]

Read More… from COVID conspiracy theorists

Covid vaccines – all you need to know

Covid vaccines – all you need to know from Emma Hammett of First Aid for Life. As a registered nurse in the midst of this crisis, I wanted to do my bit to help. The vaccination programme is critical to us emerging and rebuilding our lives and so I volunteered as a vaccinator. The training […]

Read More… from Covid vaccines – all you need to know

COVID-19 Series: Vaccines and living with the virus – Episode 50

vaccine

This episode of the COVID-19 Series will feature an interview with Sir Jeremy Farrar, Director of the Wellcome Trust. In an interview with Professor Sir Simon Wessely, the two will discuss topics including the latest news on vaccines, international developments, if it is possible for governments to really “follow the science”, and whether we can live with […]

Read More… from COVID-19 Series: Vaccines and living with the virus – Episode 50

Webinar: Trusting science in a time of crisis

science

As we face the largest global health crisis of a generation, the role of science, and the trust we place in scientists, has taken centre stage. In a special National Science Week edition of The University of Melbourne‘s Dean’s Lecture Series, four speakers will explore how and why people trust – or distrust – science […]

Read More… from Webinar: Trusting science in a time of crisis

RSM COVID-19 Series | Episode 20: Vaccines

pandemic response

A safe and effective vaccine against COVID-19 is generally regarded as the only way out of the COVID-19 crisis, especially if a widely predicted second wave develops. In this episode, RSM President-Elect Roger Kirby is joined by Professor Robin Shattock, Head of Mucosal Infection and Immunity at Imperial College London and Dr Thomas Breuer, Chief […]

Read More… from RSM COVID-19 Series | Episode 20: Vaccines

Imperial social enterprise to accelerate low-cost COVID-19 vaccine

vaccine

Imperial College London has formed a new social enterprise VacEquity Global Health (VGH) to bring its COVID-19 vaccine to the world. For the UK and low-income countries abroad, Imperial and VGH will waive royalties and charge only modest cost-plus prices to sustain the enterprise’s work, accelerate global distribution and support new research. The social enterprise’s […]

Read More… from Imperial social enterprise to accelerate low-cost COVID-19 vaccine

Vaccines Manufacturing and Innovation Centre Signs First Industry Partnership

vaccines

The Vaccines Manufacturing and Innovation Centre (VMIC), a not-for-profit organisation established to provide the UK’s first strategic vaccine development and advanced manufacturing capability has signed its first industry partnership agreement with gene and cell therapy group Oxford Biomedica plc. The agreement signed today involves the organisations collaborating to enable scaled-up manufacture of viral vector based […]

Read More… from Vaccines Manufacturing and Innovation Centre Signs First Industry Partnership

RSM webinar: Covid-19 vaccines

vaccines

COVID-19 Series: Vaccines Episode 20 will be broadcast on zoom on Tue 9 Jun 2020 from 12:30pm to 1:00pm. Key speakers: Professor Robin Shattock, Head of Mucosal Infection and Immunity at Imperial College London. Dr Thomas Breuer, Chief Medical Officer at GSK Vaccines. A safe and effective vaccine against COVID-19 is generally regarded as the only way […]

Read More… from RSM webinar: Covid-19 vaccines

Cochrane supports safety & effectiveness of MMR vaccines

New evidence published in the Cochrane Library today finds MMR, MMRV and MMR+V vaccines are effective and that they are not associated with increased risk of autism. Measles, mumps, rubella and varicella (also known as chickenpox) are infectious diseases caused by viruses. They are most common in children and young adults, and can lead to […]

Read More… from Cochrane supports safety & effectiveness of MMR vaccines